India's lower house of Parliament has passed the patents (Amendments) Bill, but not before the government failed to defeat an Opposition-sponsored motion against postponement of its discussion. Later, the motion was carried in the second stage with a margin of 14 votes.
The Opposition maintained its pressure even during the clause-by-clause consideration of the amending bill that would facilitate the filing of patent applications in line with the World Trade Organization agreement, to which India is a signatory.
A few days before the bill was adopted, the government announced duty exemptions on life-saving equipment in its 1995-96 budget proposals. This is expected to give a massive boost to health care in India. The exemptions would facilitate hospital acquisitions of equipment such as color dopplers for cardiac and other applications, dialysis machines and linear accelerators for cancer patients.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze